1 Department of Cardiology, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA.
2 Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
3 Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA.
4 Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Received 13 May 2022. Revision received 5 July 2022.
Accepted 12 September 2022.
This study was funded by the California Heart Center Foundation.
The authors declare no conflicts of interest.
All authors were involved in the study design and data interpretation. O.S., J.M., E.P., and J.K. were involved in data analysis. O.S. and J.K. drafted the article. All authors commented on the article and approved the final report.
Supplemental digital content (SDC) is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.transplantjournal.com).
Correspondence: Jon A. Kobashigawa, MD, Department of Cardiology, Cedars-Sinai Smidt Heart Institute, 127 S San Vicente Blvd, Los Angeles, CA 90048. ([email protected]).
